OR WAIT null SECS
August 20, 2021
UK's ABPI responds to the latest revisions being made to NICE methods for assessment of drugs and devices.
August 19, 2021
Curia plans to expand the site’s commercial capabilities with this move.
Merck KGaA has partnered with Telix Pharmaceuticals to conduct combination clinical studies for cancer therapy.
Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.
The collaboration will focus on the interactions between WTX-124 indukine and KEYTRUDA (pembrolizumab).
A new method developed by the NIH bypasses genetic RNA extraction, simplifying the testing process.
August 18, 2021
FDA approves Merck’s Welireg for the treatment of adult patients with von Hippel-Lindau disease who require therapy for tumor growth.
WHO’s solidarity plus trial will enroll hospitalized patients to test artesunate, imatinib, and infliximab in hospitalized COVID-19 patients.
BlackBerry’s QNX real-time operating system may create cybersecurity vulnerabilities, according to FDA.
Lilly’s insulin, lyumjev, receives FDA approval for an expanded label.